The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives
Open accessAbstract
According to Darwin’s theory, endless evolution leads to a revolution. One such example is the Clustered Regularly Interspaced Palindromic Repeats (CRISPR)–Cas system, an adaptive immunity system in most archaea and many bacteria. Gene editing technology possesses a crucial potential to dramatically impact miscellaneous areas of life, and CRISPR–Cas represents the most suitable strategy. The system has ignited a revolution in the field of genetic engineering. The ease, precision, affordability of this system is akin to a Midas touch for researchers editing genomes. Undoubtedly, the applications of this system are endless. The CRISPR–Cas system is extensively employed in the treatment of infectious and genetic diseases, in metabolic disorders, in curing cancer, in developing sustainable methods for fuel production and chemicals, in improving the quality and quantity of food crops, and thus in catering to global food demands. Future applications of CRISPR–Cas will provide benefits for everyone and will save countless lives. The technology is evolving rapidly; therefore, an overview of continuous improvement is important. In this review, we aim to elucidate the current state of the CRISPR–Cas revolution in a tailor-made format from its discovery to exciting breakthroughs at the application level and further upcoming trends related to opportunities and challenges including ethical concerns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
Optimization of genome editing through CRISPR-Cas9 engineering
Zhang, J.-H., Adikaram, P. R., Pandey, M., Genis, A., & Simonds, W. F. (2016) · Bioengineered · doi:10.1080/21655979.2016.1189039 · Cited by 103
Zhang, S., Guo, F., Yan, W., Dai, Z., Dong, W., Zhou, J., Zhang, W., Xin, F., & Jiang, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00459 · Cited by 103
Wang, Y., Wei, D., Zhu, X., Pan, J., Zhang, P., Huo, L., & Zhu, X. (2016) · Scientific Reports · doi:10.1038/srep31145 · Cited by 102
Duchêne, B. L., Cherif, K., Iyombe-Engembe, J.-P., Guyon, A., Rousseau, J., Ouellet, D. L., Barbeau, X., Lagüe, P., & Tremblay, J. P. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.010 · Cited by 99
Nielsen, M. L., Isbrandt, T., Rasmussen, K. B., Thrane, U., Nielsen, J. B., Larsen, T. O., & Mortensen, U. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169712 · Cited by 98
Puchta, H. (2015) · The Plant Journal · doi:10.1111/tpj.13100 · Cited by 92
Characterizing leader sequences of CRISPR loci
Alkhnbashi, O. S., Shah, S. A., Garrett, R. A., Saunders, S. J., Costa, F., & Backofen, R. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw454 · Cited by 89
OsPRX2 contributes to stomatal closure and improves potassium deficiency tolerance in rice
Mao, X., Zheng, Y., Xiao, K., Wei, Y., Zhu, Y., Cai, Q., Chen, L., Xie, H., & Zhang, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.045 · Cited by 88
Bjursell, M., Porritt, M. J., Ericson, E., Taheri‐Ghahfarokhi, A., Clausen, M., Magnusson, L. U., Admyre, T., Nitsch, R., Mayr, L. M., Aasehaug, L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.02.015 · Cited by 88
Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum
Özcan, A., Pausch, P., Linden, A., Wulf, A., Schühle, K., Heider, J., Urlaub, H., Heimerl, T., Bange, G., & Randau, L. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0274-8 · Cited by 83
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
Wollebo, H. S., Bellizzi, A., Kaminski, R., Hu, W., White, M. K., & Khalili, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136046 · Cited by 81
CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells
Bu, X., Kato, J., Hong, J. A., Merino, M. J., Schrump, D. S., Lund, F. E., & Moss, J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx137 · Cited by 78
Ludman, M., Burgyán, J., & Fátyol, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-01050-6 · Cited by 77
Khosravi, M. A., Abbasalipour, M., Concordet, J., Berg, J. V., Zeinali, S., Arashkia, A., Azadmanesh, K., Buch, T., & Karimipoor, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.042 · Cited by 76
A Dual-Plasmid CRISPR/Cas System for Mycotoxin Elimination in Polykaryotic Industrial Fungi
Liu, W., An, C., Shu, X., Meng, X., Yao, Y., Zhang, J., Chen, F., Xiang, H., Yang, S., Gao, X., et al. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00178 · Cited by 72
Xu, C., Huang, R., Teng, L., Jing, X., Hu, J., Cui, G., Wang, Y., Cui, Q., & Xu, J. (2015) · Nature Communications · doi:10.1038/ncomms7900 · Cited by 70
Weyda, I., Yang, L., Vang, J., Ahring, B. K., Lübeck, M., & Lübeck, P. S. (2017) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2017.01.015 · Cited by 67
TET-mediated epimutagenesis of the Arabidopsis thaliana methylome
Ji, L., Jordan, W. T., Shi, X., Hu, L., He, C., & Schmitz, R. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03289-7 · Cited by 66
Liu, Y., Yang, Y., Kang, X., Lin, B., Qian, Y., Song, B., Gao, G., Chen, Y., Sun, X., Li, X., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.11.010 · Cited by 65
Zuo, Y., Feng, F., Qi, W., & Song, R. (2019) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12798 · Cited by 62
Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer
Chen, C., Changou, C. A., Hsieh, T., Lee, Y., Chu, C.-Y., Hsu, K., Wang, H., Lin, Y., Lo, Y.-N., Liu, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2066 · Cited by 59
Wang, X., Wang, X., Guo, R., Tu, M., Wang, D., Guo, C., Wan, R., Li, Z., Wang, X., & Wang, X. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00097 · Cited by 58
Why Gene Editors Like CRISPR/Cas May Be a Game-Changer for Neuroweapons
DiEuliis, D., & Giordano, J. J. (2017) · Health Security · doi:10.1089/hs.2016.0120 · Cited by 58
Gene transcription repression in Clostridium beijerinckii using CRISPR‐dCas9
Wang, Y., Zhang, Z.-T., Seo, S.-O., Patrick, L., Lu, T., Jin, Y., & Blaschek, H. P. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26020 · Cited by 56
Development of a CRISPR/Cas9-mediated gene-editing tool in Streptomyces rimosus
Jia, H., Zhang, L., Wang, T., Han, J., Tang, H. J., & Zhang, L. (2017) · Microbiology · doi:10.1099/mic.0.000501 · Cited by 54
Isgrò, A., Gaziev, J., Sodani, P., & Lucarelli, G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05543.x · Cited by 46
Analysis of CRISPR-Cas System in Streptococcus thermophilus and Its Application
Hao, M., Cui, Y., & Qu, X. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00257 · Cited by 43
Schleidgen, S., Dederer, H.-G., Sgodda, S., Cravcisin, S., Lüneburg, L., Cantz, T., & Heinemann, T. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00487-1 · Cited by 43
Structure of a type IV CRISPR-Cas ribonucleoprotein complex
Zhou, Y., Bravo, J. P. K., Taylor, H. N., Steens, J. A., Jackson, R. N., Staals, R. H. J., & Taylor, D. W. (2021) · iScience · doi:10.1016/j.isci.2021.102201 · Cited by 42
CRISPR–Cas13a: Prospects for Plant Virus Resistance
Khan, M. Z., Amin, I. U., Hameed, A., & Mansoor, S. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.05.005 · Cited by 41
The Promise of CRISPR for Human Germline Editing and the Perils of “Playing God”
Locke, L. G. (2020) · The CRISPR Journal · doi:10.1089/crispr.2019.0033 · Cited by 41
Metabolic engineering of Pichia pastoris for production of isopentanol (3-Methyl-1-butanol)
Siripong, W., Angela, C., Tanapongpipat, S., & Runguphan, W. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2020.109557 · Cited by 41
Vilariño, M., Suchy, F. P., Rashid, S. T., Lindsay, H. A., Reyes, J. M., McNabb, B. R., van der Meulen, T., Huising, M. O., Nakauchi, H., & Ross, P. J. (2018) · Transgenic Research · doi:10.1007/s11248-018-0094-x · Cited by 40
One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
Jiménez, A., Muñoz‐Fernández, G., Ledesma‐Amaro, R., Buey, R. M., & Revuelta, J. L. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13425 · Cited by 39
Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape
Ferreira, R., David, F., & Nielsen, J. (2018) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-017-2000-6 · Cited by 38
Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene
Gergen, J., Coulon, F., Crénéguy, A., Elain-Duret, N., Gutiérrez-Guerrero, A., Pinkenburg, O., Verhoeyen, E., Anegón, I., Nguyen, T. H., Halary, F. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192602 · Cited by 38
Tso, F. Y., West, J. T., & Wood, C. A. (2019) · Journal of Virology · doi:10.1128/jvi.02183-18 · Cited by 38
Gomez, M. A., Lin, Z. D., Moll, T., Chauhan, R. D., Renninger, K., Beyene, G., Taylor, N. J., Carrington, J. C., Staskawicz, B., & Bart, R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/209874 · Cited by 37
CRISPR Cautions: Biosecurity Implications of Gene Editing
West, R. M., & Grönvall, G. K. (2020) · Perspectives in biology and medicine · doi:10.1353/pbm.2020.0006 · Cited by 35
Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer
Li, F., Ng, W., Luster, T. A., Hu, H., Sviderskiy, V. O., Dowling, C. M., Hollinshead, K. E. R., Zouitine, P., Zhang, H., Huang, Q., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3782 · Cited by 35
Pyne, M. E., Sokolenko, S., Liu, X., Srirangan, K., Bruder, M. R., Aucoin, M. G., Moo‐Young, M., Chung, D. A., & Chou, C.-H. P. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01354-16 · Cited by 32
New approaches to gene and cell therapy for hemophilia
Ohmori, T., Mizukami, H., Ozawa, K., Sakata, Y., & Nishimura, S. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12926 · Cited by 30
Applications of CRISPR‐Cas9 in gynecological cancer research
Zhang, W., Liu, Y., Zhou, X., Zhao, R., & Wang, H. (2020) · Clinical Genetics · doi:10.1111/cge.13717 · Cited by 25
Edição genética: riscos e benefícios da modificação do DNA humano
Furtado, R. N. (2019) · Revista Bioética · doi:10.1590/1983-80422019272304 · Cited by 23
CRISPR Libraries and Screening
Poirier, J. T. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.002 · Cited by 17
Miyamoto, T., Akutsu, S. N., Tauchi, H., Kudo, Y., Tashiro, S., Yamamoto, T., & Matsuura, S. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rry007 · Cited by 11
Soga, K., Nakamura, K., Ishigaki, T., Kimata, S., Ohmori, K., Kishine, M., Mano, J., Takabatake, R., Kitta, K., Nagoya, H., et al. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.125426 · Cited by 10
Therapeutic targets and investigated treatments for Ataxia-Telangiectasia
Lavin, M. F., Yeo, A. J., Kijas, A. W., Wolvetang, E. J., Sly, P. D., Wainwright, C. E., & Sinclair, K. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1254618 · Cited by 7
Applications of CRISPR-Cas in Ageing Research
Haston, S., Pozzi, S., & González-Meljem, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_11 · Cited by 5
CRISPR in HIV: Dangers of CCR5 Deletion
Rusconi, S., & Giacomelli, A. (2020) · Future Virology · doi:10.2217/fvl-2020-0039 · Cited by 2
Cited by
AI-powered therapeutic target discovery
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341
Biotechnological methods to remove microplastics: a review
Anand, U., Dey, S., Bontempi, E., Ducoli, S., Vethaak, A. D., Dey, A., & Federici, S. (2023) · Environmental Chemistry Letters · doi:10.1007/s10311-022-01552-4 · Cited by 255
Self-citationThe Multifaceted Biology of PCSK9
Seidah, N. G., & Prat, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab035 · Cited by 232
Cellular landscaping of cisplatin resistance in cervical cancer
Bhattacharjee, R., Dey, T., Kumar, L., Kar, S., Sarkar, R., Ghorai, M., Malik, S., Jha, N. K., Vellingiri, B., Kesari, K. K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113345 · Cited by 93
Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants
Alghuthaymi, M. A., Ahmad, A., Khan, Z., Khan, S. H., Ahmed, F. K., Faiz, S., Nepovimova, E., Kuča, K., & Abd-Elsalam, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147456 · Cited by 83
“Genetic engineering of plants is at the core of environmental sustainability efforts, natural product synthesis for pharmaceuticals, and agricultural crop engineering and can help meet the needs of the growing human population under changing global climatic conditions [1,2].”
BackgroundSelf-citation
Metadata
- Authors
- Nidhi, S., Anand, U., Oleksak, P., Tripathi, P., Lal, J. A., Thomas, G., Kuca, K., & Tripathi, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-03-24
- Volume
- 22
- Issue
- 7
- Pages
- 3327
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3138897353
- Cited by
- 276
- References
- 250
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.